PubMed · 11383359
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
P Bol. 2001. [Depression].. https://pubmed.ncbi.nlm.nih.gov/11383359/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Current knowledge of stereoselective pharmacokinetics and different potencies of drug enantiomers requires the performance of stereoselective analysis during therapeutic drug monitoring in clinical practice. However, in the case of the new antidepressant drug reboxetine, no effort has been made so far to find a such a suitable system. Therefore, as a step towards developing an enantioselective bioanalytical method for reboxetine and the O-desethylreboxetine metabolite, three stereoselective chromatographic approaches have been investigated. Several chiral columns were tested, among them Chiral-AGP, ChiraGrom 2 and Chiral-CBH, which were able to simultaneously separate the two compounds into enantiomers in total running times of 28, 18 and 12 min, respectively.
Explore the source record for details and available documents.
Explore the source record for details and available documents.